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611Pluripotent stem cell growth modelsIntroduction
Human pluripotent stem cells (hPSCs), including human
embryonic stem cells (hESCs) and induced pluripotent stem
cells (iPSCs), are potentially important resources for regener-
ative medicine-based cell replacement. However, this ap-
proach has not been efficiently implemented, due in part to
currently used inefficient cell culture and differentiation
strategies, which are heavily based on cell culture as colonies
and aggregated embryoid bodies (EBs) (Chen et al., 2014;
Mallon et al., 2006; Thomson et al., 1998; Xu et al., 2001).
These methods have led to time-consuming production of
relatively low numbers of cells (Hartung et al., 2010; Kehoe
et al., 2010; Serra et al., 2012), heterogeneous cellular and
molecular states (Bendall et al., 2007; K.G. Chen et al., 2012;
Moogk et al., 2010; Stewart et al., 2006), and frequent reports
of chromosomal abnormalities (reviewed in Baker et al., 2007;
Lee et al., 2013). Certain chromosomal alterations such as
trisomies 12, 17, and 20 have the capacity to confer growth
advantages as indicated by comparative genetic analyses
(Amps et al., 2011; Catalina et al., 2008; Draper et al., 2004;
Lefort et al., 2008).
The relationship between heterogeneous cellular states
and the incidence of chromosomal abnormalities remains
unclear. Thus far, there is no direct proof that the colony-
type culture method is responsible for the reported chromo-
somal abnormalities. However, it is conceivable that the
heterogeneity of hPSC colonies (induced by cellular stress)
might result in the selection of cells with growth advantages,
which are usually bestowed by mutations or chromosomal
alterations (Baker et al., 2007; Lee et al., 2013). This cellular
stress may be derived from unwanted growth factors or
conditions, which could be categorized as abnormal metabolic
pathways, deficiency in nutrient or growth factors, and
excessive apoptotic or differentiation signals. These subop-
timal conditions may directly or indirectly contribute to
insufficient cell production, cellular heterogeneity, and
chromosomal instability of hPSCs.
It is imperative that we develop efficient culture methods
that can overcome the obstacles found in the current culture
systems. Moreover, new culture methods should be optimized
for production of clinically relevant cell numbers, tissue
morphogenesis, high-throughput drug discovery, and effi-
cient assays of cellular stress. A comprehensive analysis of
different cell culture protocols for hPSC is available in a
recent review (Chen et al., 2014). Here, we will focus on the
fundamental principles of developmental biology and core
signaling pathways that underlie different growth methods.
We will further discuss the relationship between the develop-
ment of early stage embryos and the mechanisms underlying
hESC heterogeneity and chromosomal instability. Finally, we
will provide new insights into the development of optimal
growth models for hPSCs.Human pluripotent stem cell colonies and
aggregates recapitulate some properties of
early-stage embryo development
Unlike mouse embryonic stem cells (mESCs), which possess
high single-cell plating efficiency under dissociated conditions,both hESCs and iPSCs cannot grow as single cells under
commonly used culture conditions. Human pluripotent stem
cells are conventionally cultured as condensed colonies and
must be passaged as cell clumps to avoid cumulative apoptotic
and differentiation stress. These cells are routinely differ-
entiated toward derivatives of the three germ layers through
three-dimensional (3D) EBs. In general, colony-type and
aggregated cultures often produce heterogeneous colonies
and EBs. Hence, we frequently observe more apoptotic
activity in the center of a colony (with more spontaneously
differentiated cells at the periphery) (Figs. 1 and 2) and
complicated cystic structures after EB agglomeration (Fig. 3).
The unique structures of hESC colonies and EBs are reminis-
cent of the inner cell mass (ICM) and post-implantation
blastocysts observed during early embryo development. In
the following sections, we will discuss the links between the
structures of hPSC colonies and EBs and their developmental
counterparts.Human ES colony structure inherits epithelial features
of the ICM
The ICM is comprised of a group of epithelial-like cells, the
epithelial features of which are reflected at the intercellular
junctions and in their basement membranes (Fig. 1A). Typical
epithelial cells are tightly polarizedmonolayers with a distinct
apical surface, basal membrane, and lateral intercellular con-
junctions (Figs. 2A, B). At day 4 of compacting human
embryos, E-cadherin (E-cad), an important component of
epithelial cells, is located on the membranes where cell–
cell contacts occur. However, in the ICM, E-cad is diffusely
expressed in the cytoplasm, but not on the plasma
membrane (Alikani, 2005). Thus, the distribution of E-cad
in human preimplantation embryos appears to be an embry-
onic stage-dependent process. Electron microscopic study has
also revealed similar epithelial features in hESCs (Ullmann
et al., 2007). Intercellular interactions in both trophectoderm
and ICM cells are implemented through gap junctions, tight
junctions, and desmosome-like structures (Dale et al., 1991;
Gualtieri et al., 1992).
Laminin is another epithelial component of the basement
membrane that is expressed in the different stages of early
embryos. Matrigel, a basement membrane preparation ex-
tracted from a murine Englebreth–Holm–Swarm sarcoma
(Kleinman et al., 1982), containing laminins, as well as
collagen IV, fibronectin, and vitronectin, was found to support
robust hESC growth in defined medium (Ludwig et al., 2006)
and is used routinely for the feeder-free culture of hPSCs.
Laminin-111, the most abundant form in the Reichert's
membrane, was found under the mouse trophoblasts, which
was proposed to interact with ICM cells and induce differen-
tiation (Domogatskaya et al., 2012; Miner et al., 2004). At
least two laminin isoforms (i.e., laminin-511 and -521) have
been detected in the basement membrane of the ICM of
mammalian pre-implantation embryos (Domogatskaya et al.,
2012; Miner et al., 2004). It has been shown that laminin-511,
but not -111, supports mESC self-renewal in vitro without
leukemia inhibitory factor (LIF) or mouse embryonic fibro-
blasts (MEFs) (Domogatskaya et al., 2008). Recently, the use
of human recombinant laminin-511 has enabled long-term
self-renewal of hPSCs (Rodin et al., 2010). Thus, both E-cad
Figure 1 Early human embryo development, hESC culture, and acquisition of cellular heterogeneity. (A) Anatomical structure of
the inner cell mass (ICM) at day 8 with major cell types indicated. (B) Derivation and growth of hESCs from the ICM: A typical hESC
colony (e.g., hESCs grown on feeders) has three distinct zones in terms of its growth patterns, cell morphology, densities, differential
marker expression, and differences in response to small molecules and signaling factors. The center of a colony represents highly
compacted epiblast-like cells (EpiBL), which frequently experience either apoptotic or differential stress. The periphery is the region
that undergoes epithelial-to-mesenchymal transitions (EMTs), whereas some differentiated fibroblast-like cells (FBL) express
differential markers SSEA-1 and ABCG2 and are sensitive to BMP-4 signaling (K.G. Chen et al., 2012; Padmanabhan et al., 2012). The
region between the center and periphery of the colony represents an intermediate state of cells that undergo reversible EMTs.
Undifferentiated hESCs could be selected or adapted after serial passaging through growth-differentiation selection cycles in in vitro
growth conditions. (C) Lineage commitment from blastocyst (BC) to gastrulation, trophectoderm (TE), and extraembryonic endoderm
(EEE). The flow chart depicts the relationship among the cell types presented in panel A. EMT occurs at the primitive streak.
(D) Anatomical structure and various cell types in hESC colonies under colony-type culture conditions: hESCs undertake either
reversible EMT (that maintain the undifferentiated states) or irreversible EMT (that induce terminal differentiation). Abbreviations:
BC, blastocyst; BM, basement membrane; CTB, cytotrophoblast; EEE, extraembryonic endoderm; EEM, extraembryonic mesoderm;
EM, endometrium; EpiB, epiblast; EpiBL, epiblast-like cells; FBL, fibroblast-like cells; HB, hypoblast; HBL, hypoblast-like cells; ICM, inner
cell mass; TE, trophectoderm; STB, syncytiotrophoblast; TB, trophoblast; and TBL, trophoblast-like cells.
612 K.G. Chen et al.and some specific laminins are indispensable inmaintaining the
epithelial features of undifferentiated hESCs. Alterations of
these epithelial components in vitro during embryonic devel-
opmentmay induce differentiation and cellular heterogeneity.Figure 2 Growth models of hPSCs under various growth conditio
contains growth factors FGF2 and TGFβ on Matrigel-based extracellu
complexes: Laminin (LM), fibronectin (FN), and vitronectin (VNT)
respectively (Braam et al., 2008; Brafman et al., 2012). Diffe
epithelial-to-mesenchymal transition (EMT) states, in which the
characteristics and cells at the periphery develop mesenchymal-like
the colonies define an intermediate state that undergoes transient
(e.g., E-cad) with degradation of ECM confers cells with an irreversib
Growth models of hPSCs grown as non-colony type monolayer (NCM)
conditions as indicated in panel A. (C) Core pathways that support hP
among epithelial hPSCs, cells with an intermediate ES state, and di
EMT2) or METs (MET1 and MET2) are likely to mediate these conver
EMTs and METs are proposed and indicated with an emphasis on the d
v-akt murine thymoma viral oncogene homolog; ALK5, transforming
kinase 5; BM, basement membrane; CDH1, the gene encoding E-cad
extracellular signal-regulated kinase; FGF2, fibroblast growth facto
INT, intergrins; LM, laminin; MAPK, mitogen-activated protein kin
metallopeptidases; Nu, nucleus of the cell; p53, tumor protein p53;
culture dishes for hPSCs; RTK, receptor tyrosine kinases; Smad, SMA
homolog 2 (Drosophila); TGFβ, transforming growth factor beta; VNWithin the ICM, the embryoblast has the ability to form the
epiblast, the outer layer of a blastula that gives rise to the
ectoderm, and the hypoblast, which in turn generates extraem-
bryonic endoderm (Fig. 1C) (Carlson, 2009). Developmentally,ns. (A) Growth models of hPSC colonies in hESC medium that
lar matrices with deduced anatomical structures and molecular
mediate their effect via the α6β1, α5β1, and αVβ5 integrins
rent zones of out-growing hPSC colonies have differential
cells in the center of the colonies possess more epithelial
phenotypes. The cells between the center and the periphery of
EMT and sustains pluripotency. Loss of the epithelial markers
le EMT state with fibroblast- or trophoblast-like phenotypes. (B)
have uniform intercellular interactions under the same growth
SC growth: the model illustrates the dynamics of cellular states
fferentiated cells, in which two phases of EMTs (i.e., EMT1 and
sions. The potential regulators and pathways that control both
ifferential roles of TGFβ at different stages. Abbreviations: AKT,
growth factor, beta receptor 1, known as activin receptor-like
herin (epithelial); ColV, collagenase IV; E-cad, E-cadherin; ERK,
r 2 (basic); FN, fibronectin; GSK3, glycogen synthase kinase 3;
ase; MET, mesenchymal-to-epithelial transition; MMPs, matrix
PPJ, plastic-protein junction; PS, polystyrene surface of the cell
D family member; Snail, snail homolog 1 (Drosophila); Slug, snail
T, vitronectin; β-cat, β-catenin.
613Pluripotent stem cell growth modelsembryonic epithelial cells can change their morphology and
motility to resemble fibroblast-like mesenchymal cells, a process
known as epithelial-to-mesenchymal transition (EMT) (Carlson,
2009). The peripheral cells of the embryoblast differentiate intothe cytotrophoblast and syncytiotrophoblast, resembling the
EMTs required for implantation (Fig. 2A). The reverse process of
EMT, termedmesenchymal-to-epithelial transition (MET), can be
repeatedly observed during normal embryonic development
Figure 3 Early mammalian embryo development and embryoid body (EB) differentiation. (A) Structural presentation of mammalian
embryonic differentiation after the implantation of a blastocyte. Syncytiotrophoblasts are not shown in this figure. The figure is
adapted from the book Human Embryology and Developmental Biology (Carlson, 2009). (B) Delineation of early- and late-stage EB
formation with differentiation medium in a non-adherent culture dish. Abbreviations: CTB, cytotrophoblast; EpiB, epiblast; EpiBL,
epiblast-like cells; HB, hypoblast; HBL, hypoblast-like cells; ICM, inner cell mass; and TB, trophoblast.
614 K.G. Chen et al.(Carlson, 2009). Thus, hESCs derived from the ICM may be
considered to mimic epiblast-stage embryos before the occur-
rence of the primitive streak, where the first EMT event takes
place (Figs. 1C, 2C). It is clear now that multiple phases of EMT
and MET play pivotal roles in early embryo development and in
the generation of various types of tissues (Carlson, 2009; Thiery
et al., 2009).
It is feasible that hESC lines, derived from the ICM, have
predominantly epithelial characteristics and, to a lesser extent,
resemble cell types with mesenchyme-like propensity. Consis-
tently, expression of the epithelial marker genes CDH1, DSP and
KRT19 is significantly increased in hESCs, as opposed to that
observed in fibroblasts and partially reprogrammed iPSCs
(Ullmann et al., 2007). Moreover, EMT has also been found in
colonies of monkey ESCs and in feeder-free cultures that
frequently induce spontaneous differentiation (Behr et al.,
2005; Pratama et al., 2011). Thus, the heterogeneity of a hESC
colony might be an inherent property of the ICM, which at least
is partially attributed to irreversible EMTs (Figs. 1 and 2). It is
conceivable that the heterogeneity of the ICM is required for
consecutive three-germ layer differentiation after embryo
implantation. In vitro, the counterpart of the three germ-layer
lineage commitment is EB-mediated differentiation.EB differentiation shares some fates of implanted
blastocysts
Without growth factors that support the pluripotent state,
hESC clumps form 3D multilayer aggregates under suspension
culture conditions, usually in a non-adherent culture dish.
EB differentiation has been widely used as an intermediate
step in multilineage differentiation. As the name suggests,
these aggregates mimic many aspects of cell differentiation
during the development of early embryos (Fig. 3). Based onthe stage and structural properties, EBs can be classified into
simple and cystic EBs (Fig. 3B) (Magyar et al., 2001; Ungrin
et al., 2008). Simple EBs are 2- to 4-day spherical aggregates
(usually 100–400 μm), resembling morula-like and, to some
extent, the ICM-stage embryos. With respect to cystic EBs,
there are one ormore central cavities after day 4 in suspension
culture, which are similar to an implantedmammalian embryo
from day 7 to 12. At this stage, the embryos have established
an inner parietal endoderm enclosed cavity (i.e., primary yolk
sac) and an outer layer termed extraembryonic mesoderm
(Fig. 3A) (Carlson, 2009).
EBs are developed through intercellular adhesion, which
may involve the cadherin–β-catenin–Wnt pathway, a potent
regulatory mechanism for tissue morphogenesis (Gumbiner,
1996). Indeed, E-cad, expressed in undifferentiated hESCs, is
the initiator of early-stage EB formation and also plays a role in
later-stage EB differentiation (Dang et al., 2004). Modulation
of a specific cadherin isoform is associated with a definite cell
lineage commitment, in which expression of E-cad leads to
epithelial differentiation whereas up-regulation of N-cad
prefers a neuroepithelial fate (Twiss and de Rooij, 2013).
Moreover, spontaneous formation of primitive endoderm was
observed at the exterior surface of EBs after cell
aggregation (Maurer et al., 2008). The primitive endoderm
cells were subsequently differentiated into visceral and parietal
endoderm, and also generated a laminin–collagen-IV-enriched
basement membrane (Fig. 3B) (Li et al., 2001). Similarly, the
exterior domain of hESC EBs was stained positively for the
endoderm marker FOXA2 (Ungrin et al., 2008). Unlike their
embryonic counterpart, regular EBs do not have a thin layer of
trophoblasts (Fig. 3). Thus, the exterior surface is directly
exposed to soluble factors and nutrients in culture medium.
The permissive diffusion of soluble factors (b1000 Da)
in culture medium from the exterior to the interior of
EBs enables the formation of concentration gradients that
615Pluripotent stem cell growth modelsinfluence the differentiation outcomes (Bratt-Leal et al.,
2009). As EB development proceeds, asynchronous differ-
entiation of EBs toward the three germ-layer lineages
may be achieved. However, this heterogeneous differentiation
presents a big challenge for large-scale production of homoge-
neously differentiated cells. Numerous efforts were made to
control the size of both hESC colonies and aggregates in order
to direct differentiation trajectories (Bauwens et al., 2008). To
ensure the homogeneity of EBs, Zandstra and colleagues also
utilized a new technique to generate uniform EBs from
dissociated single-cells. The size-controlled EB formation with
the ROCK inhibitor Y-27632 ensured its homogeneity and highly
ordered structures (Ungrin et al., 2008). In addition, strategies
that influence differentiation from both the exterior and
interior of EBs can be used to efficiently direct differentiation
by controlling the extracellular microenvironment and
chemical signals (Bratt-Leal et al., 2009).
Collectively, EB-based methods may offer several benefits
for stem cell research, which include (i) use of EBs as a routine
differentiation protocol, (ii) application of EBs to study early
differentiation events of human embryos, (iii) use of geneti-
cally engineered EBs to determine the functionality of gene
mutations that are lethal to early embryos, (iv) coupling of
EB methods with new growth modules such as bioreactors to
produce large amounts of differentiated cells for therapeu-
tic use, and (v) combination of EB methods with microfluidic
bioreactors to study morphogenesis in 4D culture systems
(Chen et al., 2014). Nevertheless, we also need to consider
the disadvantages of EB methods (i.e., time-consuming
nature, cell loss, lower differentiation efficiency, and hetero-
geneous differentiation) in future pharmaceutical and clinical
applications.
Thus, both colony-type hPSC growth and EB aggregated
differentiation share many structural features of early embry-
onic development, including the heterogeneous nature of
cell growth and differentiation. It has been appreciated
that generation of heterogeneity is actually required for
lineage commitment and tissue maturation (Carlson, 2009).
However, such a heterogeneous cellular state is an unwanted
outcome for hPSC-based therapies, which usually need trans-
plantation of a pure cell population. Understanding the precise
signaling pathways that drive early embryonic development
and hESC growth would provide useful tools to control these
heterogeneous states during cell expansion and differentiation
in vitro.
Core signaling pathways depict multiple EMT
phases and cellular heterogeneity in human
pluripotent stem cells
The molecular mechanisms that maintain the epithelial
identity of hPSCs depend on apical ligand-receptor signal
transductions, intercellular adhesion (mediated by molecules
such as E-cad-conjugated β-catenin), and basement mem-
brane and ECM interactions (Figs. 2A, B). With regard
to intercellular connections, glycogen synthase kinase-3
(GSK-3) is a potent regulator of E-cad and plays a pivotal
role in EMT and in cell fate commitment. In general, GSK-3
phosphorylates Snail and initiates its proteasomal degrada-
tion, hence upregulating E-cad and concurrently inhibiting
EMT (Doble and Woodgett, 2007). However, in the case ofhESCs, when GSK-3 inhibitor (6-bromoindirubin-3′-oxime) is
added as a supplement to hESC medium to support hESC
self-renewal, EMT is inhibited, likely through activation of
the Wnt pathway (Sato et al., 2004; Ullmann et al., 2008).
Nevertheless, the role of Wnt/β-catenin in the main-
tenance of undifferentiated hESCs has been questioned
by a recent study in which the authors revealed that
Wnt/β-catenin signaling actually promotes hESC differentia-
tion, not self-renewal (Davidson et al., 2012). In general,
concurrent upregulation of E-cad and down-regulation of
metallopeptidases (such as MMP2 and MMP9), N-cadherin,
vimentin, Snail, and Slug may be essential to inhibit EMT and
differentiation (Fig. 2C) (Ullmann et al., 2008).
Interestingly, E-cad may coordinate with many molecular
events to reduce the motility and the occurrence of the
fibroblast-like cells at the periphery of hESC colonies in
various growth conditions (Ullmann et al., 2008; Ullmann
et al., 2007). E-cad may be also associated with the
arrangements of the core actin cytoskeleton and the EMT
phenotype. This E-cad-EMT reverse correlation may be
assayed by the presence of the membrane oncofetal protein
5T4, which is triggered by the addition of anti-adhesive
antibody SHE78.7 that disrupts E-cad (Eastham et al., 2007).
These data suggest that loss of E-cad and its regulators is a
critical step that initiates EMT in hESCs.
Several other signaling pathways that include the TGFβ
and phosphoinositide 3-kinase (PI3K) pathways have also
been implicated in the regulation of EMT. However, the role
of TGFβ in EMT (the differentiation vector) and maintenance
of undifferentiated hESCs is somewhat complicated. It is
believed that FGF2, activin-A, TGFβ, and their associated
receptors represent the well-characterized signaling path-
ways that maintain the undifferentiated states of epithelial
hESCs (Fig. 2) (James et al., 2005; Ludwig et al., 2006). TGFβ
maintains the pluripotent state of hESCs via receptor binding
to ALK5, which phosphorylates Smad2/3 and mediates the
nuclear localization of the Smad2/3/4 complex on the target
genes (James et al., 2005). Indeed, TGFβ alone was able to
sustain the expression of hESC markers in TeSR1 medium
(Ludwig et al., 2006).
Nonetheless, TGFβ is also involved in the regulation of
multiphase differentiation such as mesodermal induction,
myoblast proliferation, and invasion of cardiac jelly (Carlson,
2009). It controls the EMT that drives gastrulation through
the activation of Snail (Thiery et al., 2009), which then
increases vimentin and concurrently decreases the expression
of epithelial genes such asDSP, KRT19, and the E-cad encoding
gene CDH1. In addition, withdrawal of TGFβ from bovine
serum and feeders enhances reprogramming to pluripotency
in mouse cells (Li et al., 2010), likely through the MET
(Fig. 2C). TGFβ most likely modulates transient EMT events
that do not inhibit the pluripotent state of hESCs, whereas
irreversible EMTs may be the major factor that initiates
differentiation both in vitro and in vivo (Fig. 2). Taken
together, these studies highlight the complexity of TGFβ in
stem cell biology, suggesting differential roles of TGFβ in
reprogramming somatic cells, maintaining pluripotency, and
mediating lineage differentiation (Fig. 2C). A thorough under-
standing of the mechanisms that control intercellular interac-
tions would enable us to optimize growth conditions, thereby
minimizing cellular heterogeneity and abolishing potential
chromosomal abnormalities in hPSC culture.
616 K.G. Chen et al.Chromosomal instability is still a problem in
human pluripotent stem cell cultureDuring the development of early human embryos, chromosome
instability (e.g., aneuploidies, uniparental disomies, segmental
deletions, and amplifications) is a common feature in human
cleavage-stage embryonic cells (Vanneste et al., 2009). Thus,
the chromosomes of hPSCs and their derivatives might be
similarly altered at any stage during in vitro cell processing.
Although most lines were reported to be cytogenetically
normal, there was a substantial number of cell lines that
acquire chromosomal changes after long-term culture, partic-
ularly on chromosomes 1, 12, 17 and 20 (reviewed in Baker et
al., 2007; Lee et al., 2013). Recently, Benvenisty and colleagues
analyzed chromosomal changes in 104 hPSC lines, including 66
hiPSC and 38 hESC samples from 18 different studies. They
identified ~20% abnormal lines, of which ~9% of the lines had at
least one trisomy (Mayshar et al., 2010). In a second cohort
study, Andrews and colleagues reported 34% abnormal karyo-
types in 129 hPSC lines, in which 20% of cytogenetically normal
lines carried a conserved amplicon at 20q11.12 (Amps et al.,
2011). These studies define a putative rate of chromosomal
abnormalities, ranging from 20% to 54%. The estimated rates for
genomic changes could be even higher if we could include
undefined small genomic changes such as point mutations.
It is believed that prolonged culture in vitro triggers
selection of variant cells that have a higher tendency for
survival and self-renewal (Baker et al., 2007; Lee et al.,
2013). Notably, the methods employed for hPSC passaging
may have a significant impact on chromosomal changes. It
has been shown that hPSCs with enzymatic mass-passaging
have a significant increase (i.e., 2-fold) in chromosomal
abnormalities when compared with those cells using a manual
cut-and-paste passaging technique (P = 0.017) (Amps et al.,
2011). Nevertheless, the molecular basis that leads to
chromosomal instability in hPSCs remains unclear. Recent
studies have linked chromosomal abnormalities to impaired
DNA damage response and cell cycle checkpoint control
(e.g., failure to activate CHK1 in hPSCs) (Desmarais et al.,
2012; Hyka-Nouspikel et al., 2012). These studies highlight a
potential important protective mechanism that hPSCs main-
tain genomic stability by eradicating damaged cells through
apoptosis, rather than DNA repair or DNA homologous
recombination. Not surprisingly, Andrews and colleagues
were able to map the anti-apoptotic gene BCL2L1 on the
conserved amplicon at 20q11.12, which may confer enhanced
antiapoptotic activity in hPSCs with a normal karyotype (Amps
et al., 2011).
Genomic changes at the chromosomal or single nucleotide
level likely contribute to the variability of the pluripotent
states and differentiation potential. These changes can be
acquired and accumulated during cell culture because of
suboptimal growth media, inappropriate extracellular ma-
trices, and dysregulated cell signals (Baker et al., 2007).
With regard to hPSC culture, our goal is to avoid or minimize
the heterogeneity and the occurrence of these potentially
harmful alterations that may possess tumorigenic effects.
Notably, the chromosomal instability rates observed in hPSC
are predominantly derived from prolonged hPSC culture as
colonies on MEFs and Matrigel. To improve upon colony-
type-based culture methods, considerable efforts have beenmade to develop alternative culture platforms for efficient
hPSC expansion, differentiation, and high-throughput assays.
Robust growth models for pluripotent stem cell
growth and assayThe need for clinically relevant quantities of hPSCs used
for stem cell therapies and pharmaceutical applications
promotes the development of compatible hPSC growth
platforms. Stem-cell based therapies usually demand
desired cell numbers ranging from 107 to 1010 or beyond.
For example, repair of a 20-mm bone defect requires
about 2 × 107 osteoblasts. Approximately 2 × 109 differenti-
ated cardiomyocytes or insulin-producing beta cells are
needed to replace the damaged tissues after myocardial
infarction or for islet transplantation (Kehoe et al., 2010).
The development of suspension culture and single-cell
based growth protocols for manufacturing hPSCs is an active
area of research. We have recently presented a comprehensive
analysis of different culture protocols (Chen et al., 2014). In the
following sections, we will focus on several new methods based
on the variability, heterogeneity, chromosomal instability,
and potential applications. These methods include suspen-
sion culture of undifferentiated cells, single-cell passaging,
and non-colony type monolayer (NCM).
Suspension culture in stirred-suspension bioreactors
Current suspension culture methods require that hESC
colonies are dissociated into small clumps to maintain the
viability and pluripotency of the cells. To overcome the size
differences and variability of cell seeding, several groups
have adapted their methods from seeding small aggregates
to single-cells in stirred-suspension vessels (V.C. Chen et
al., 2012; Kehoe et al., 2010; Krawetz et al., 2010; O'Brien
and Laslett, 2012; Steiner et al., 2010). Typically, single
cells dissociated from hPSC colonies are incubated with
MEF-conditioned medium containing 10% Matrigel and
10 μM Y-27632 for 30 min to facilitate initial intercellular
aggregation and introduced into spinner flasks with an
agitation rate at 60 rpm for approximately 6 days followed
by passaging (Kehoe et al., 2010). The suspension cell clusters
were passaged weekly by mechanically triturating the cells
into smaller aggregates in the presence of Y-27632. These
investigators believed that the suspended “EB-like” clusters of
hESCs maintained their pluripotency and did not turn into
differentiated EBs (Steiner et al., 2010).
Benefits, pitfalls, and challenges of suspension culture
The benefits of culturing hPSCs by stirred-suspension
bioreactors could be substantial: (i) rational scalability,
(ii) reasonable hPSC expansion rates, (ii) elimination of feeder
and matrices, (iv) long-term maintenance of pluripotency
(over 20 passages), and (v) compatibility with several formats
such as microcarriers and microencapsulation (Chen et al.,
2014). Not surprisingly, Chen and colleagues demonstrated
that they could maintain the pluripotency of hESCs and
expanded H9 (WA09) cells over 20 passages in suspension
culture, with a total fold expansion over 1 × 1013 (V.C.
Chen et al., 2012). This represents approximately 4.3-fold
617Pluripotent stem cell growth modelsexpansion per passage in 3–4 days, which is much better than
adherent colonies (K.G. Chen et al., 2012). Encouragingly, the
karyotype appears to be normal after long-term suspension
culture in at least 10 different laboratories. Large cohort
analyses of chromosomal stability at a higher resolution
are necessary to ensure its superiority to other culture
methods. Nonetheless, the current methods still have several
pitfalls that need to be overcome prior to clinical applications,
which include: (i) reduced cellular viability in bioreactors
due to agitation-induced shear, (ii) dependence on the con-
stant use of Y-27632, which induces aggregation, to improve
cell survival rates, and (iii) increased differentiation and
cellular heterogeneity.
Single-cell passaging and short-term assays
Single-cell passaging using ROCK inhibitors is now considered a
routine technique to promote single-cell survival (Watanabe et
al., 2007). Ding and coworkers demonstrated that several novel
synthetic molecules could dramatically promote cloning effi-
ciency of dissociated hESCs by enhancing ECM-mediated in-
tegrin activity (Xu et al., 2010). Wu and colleagues assessed the
effects of small molecule combinations on colonies derived
from dissociated single cells and found several small molecule
cocktails support long-term maintenance of hESCs (Tsutsui et
al., 2011). This method can be used to dissociate hPSC colonies
to perform single-cells assays, cryopreservation, and gene-
tic manipulation. However, the majority of studies using
single-cell passaging techniques employed low-density cell
seeding and hence produced colonies. In addition, long-term
single cell culture may induce chromosomal abnormalities.
Non-colony type monolayer (NCM) culture
We and others have recently developed a culture method
based on single-cell passaging and NCM growth (K.G. Chen
et al., 2012; Kunova et al., 2013). The key element in
this technology is high-density single-cell seeding, thereby
permitting uniform multicellular association and avoiding the
formation of colonies (Fig. 2B). There are many potential
advantages to applying NCM for hPSC biology. An immediate
benefit of the NCM method is to accurately control growth
rates, which yield approximately 3–4 fold average cell ex-
pansion per passage in 3–4 days, comparable to the outcomes
from some suspension cultures (Chen et al., 2014). The de-
monstrated scalability of NCM culture to different sizes of
culture dishes may ensure hPSC expansion using currently
compatible cell culture systems to produce clinically relevant
cell quantities. Importantly, the NCM method aims to homo-
genize heterogeneous cellular states in hPSC colonies. Indeed,
cells under NCM conditions showed a more homogeneous
response to signal molecules such as BMP-4 compared to the
same cells in colony-type culture (K.G. Chen et al., 2012).
In general, global gene expression patterns, determined
by cDNA microarray assays, were found to be similar to
each appropriate colony culture in three hPSC lines, with
correlation ranges from 0.91 to 0.94. No EMT-related gene
clusters were significantly increased in hPSCs under NCM
conditions (K.G. Chen et al., 2012). Notably, the cell yields
under NCM conditions are better than colony-type culture,
but less than suspension culture methods (Chen et al., 2014).In our previous study, there were approximately 13% (2/16)
lines showing chromosomal abnormalities (K.G. Chen et al.,
2012). Since hPSCs under NCM conditions were adapted
from previous colony-type culture, it is unclear whether
the chromosomal abnormalities observed in NCM culture
were due to the selection of preexisting mutant cells of
the colony-type culture or generated de novo under NCM.
Further comparative studies are needed to clarify this issue.
Current challenges and future directions
Obviously, colony type, non-colony type, and aggregated
cultures show many advantages in hPSC research. However,
each method has its own limitations, which might undermine
its capacity to produce clinical-grade hPSCs. In the near
future, we need to completely control the variability, hetero-
geneity, and chromosomal instability to ensure faithful hPSC
expansion and differentiation. A systematic understanding of
the mechanisms that contribute to the refractory properties of
hPSC culture would facilitate the achievement of these goals.
Moreover, development of hierarchical growth models for
organogenesis would also have great clinical potential.
Control hPSC survival and fates with small molecules
The use of small molecules that inhibit or activate core
signaling pathways provides a powerful approach to support
hPSC survival and direct lineage commitment. However, the
long-term effects of small molecules on hPSC genomic
integrity and differentiation capacities have not been carefully
evaluated. For example, several culture protocols (as discussed
above) require the use of the ROCK inhibitor Y-27632 to
enhance single-cell plating and stabilize intercellular aggrega-
tions at every cell passage. Thus, the effects of Y-27632 on
global gene expression and genomic stability should be carefully
evaluated. Under enzymatically dissociated conditions,
damaged single cells are supposed to be eliminated by
programmed cell death or apoptosis. It is unclear if ROCK
inhibition-mediated single-cell survival also preserves apo-
ptotic cells that might harbor potential genomic mutations.
Verification of these mechanistic details would provide new
strategies to maintain genomic integrity of hPSCs.
Nevertheless, further modifications and characterization
of single-cell-based methods (such as suspension culture and
NCM) are necessary to ensure its wide application for directed
differentiation. First, to induce the cells to a specific precursor
stage would facilitate directed differentiation of hPSCs under
various culture conditions. It is likely that Y-27632-based NCM
culture would enhance the differentiation efficiency of hPSCs
toward neuroectodermal cells (K.G. Chen et al., 2012).We have
also tested the effects of various small molecules that interact
with ROCK signaling pathways on both single-cell plating
and NCM growth. We found that Y-39983 (ROCK I inhibitor),
phenylbenzodioxane (ROCK II inhibitor), and thiazovivin (a
novel ROCK inhibitor) can also modulate single-cell plating and
promote NCM growth. Theoretically, these small moleculesmay
be also used for suspension culture and single-cell based assays.
Furthermore, high-throughput screening would enable us to
identify the next-generation of small molecules that drive
directed differentiation of hPSCs. Second, the development of
single-cell based methods without the use of small molecules,
618 K.G. Chen et al.such as Y-27632, would be potentially important for cell
expansion and drug screening. The use of human recombinant
laminin-521 enables single-cell plating, thus permitting us to
establish NCM and suspension culture without the aid of
Y-27632 and to produce homogeneous hPSCs in a chemically
defined environment (Chen et al., unpublished data). Finally,
it would be also possible to integrate optimized NCM and
suspension cultures into a well-controlled multidimensional
environment for tissue morphogenesis or organogenesis.Figure 4 Intercellular interactions mediated by autocrine and
morphogenesis. (A) Stem cell niche maintenance exemplified by t
Various intercellular interactions are also depicted. (B) Modes of int
and self-organization (morphogenesis). Abbreviations: hdFs, hESC-d
IGF1R, insulin-like growth factor 1 receptor.Modulation of intercellular interactions
for organogenesis
Stem-cell niches, a hub for stem cell renewal and differen-
tiation, are spatially oriented, temporally controlled, and
usually heterogeneous micro-environments in mammalian
tissues. ES cell fate determination can be traced in a 3D
stem cell niche (e.g., in hair-follicles) in animal models
(Rompolas et al., 2013). It is unclear how hPSC niches areparacrine signalings maintain stem cell niches and induce
he interaction between IGF-II (from hdFs) and IGF1R of hESCs.
ercellular interactions induce hPSC differentiation, maturation,
erived fibroblast-like cells; IGF-II, insulin-like growth factor 2;
619Pluripotent stem cell growth modelscreated in vitro microenvironment. Knowledge from both
developmental biology and various hPSC culture models
(Figs. 1–4) revealed that both autocrine and paracrine
signaling may play an important role in hPSC self-renewal,
lineage differentiation, and tissue specification in an artificial
stem cell niche.
Direct cell–cell interactions mediated by
autocrine signaling
This type of interaction defines self-secretory ligands
binding at corresponding receptors of the same cells or the
same types of cells (Fig. 4). These direct interactions may
be exemplified by Notch signaling which promotes neural
differentiation of hESCs. Activation of a highly conserved
Notch pathway endorses neural lineage commitment in both
mESCs and hESCs (Lowell et al., 2006) and improves motor
skills after ischemic injury in adult rat brain (Androutsellis-
Theotokis et al., 2006). Stromal cells that express Notch ligands
also encourage neural specification of hESCs. Hence, incom-
plete activation of endogenous Notch results in heterogeneous
lineage commitment. This neural commitment also necessi-
tates a parallel signaling through the FGFR, highlighting the
significance of cross-talk between core signaling pathways.
Indirect cell–cell interactions via paracrine signaling
Pluripotent stem cell fates are certainly influenced by
extrinsic signals produced from heterogeneous types of
cells. Paracrine signaling from different types of cells may
have differential effects on hPSC fates. It has been shown
that interplay between IGF-II (secreted from hESC-derived
fibroblast-like cells, i.e., hdFs) and IGF1R (constitutively
expressed in hESCs) promotes hESC self-renewal and the
pluripotent state (Fig. 4A) (Bendall et al., 2007). Moreover,
when hESCs were cocultured with human mesenchymal and
umbilical vein endothelial cells, they formed self-organized
miniorganoids (i.e., liver buds) (Takebe et al., 2013). Thus,
heterogeneous signaling appears to be required to induce
lineage differentiation and subsequent tissue morphogene-
sis (Fig. 4B). The generation of miniorganoids provides a
proof-of-concept experiment that organogenesis can pro-
ceed in a well-defined 3D environment. In the coming years,
we anticipate using completely defined growth factors and
small molecules to replace heterogeneous types of cells and to
generate pure populations of desired cells for transplantation
therapy in patients.
Conclusions
Human pluripotent stem cell growth models based on colony-
type culture are widely used in stem cell research. However,
these low efficient methods induce EMT, multicellular
heterogeneity, and substantial genomic instability. Emerging
hPSC growth models (such as NCM and suspension culture of
undifferentiated hPSCs) provide robust and scalable expansion
of hPSCs as well as many other utilities, making them ideal
methods to complement colony-type culture. With further
understanding of core signaling pathways that control
intercellular interactions, efficient production of clinical-
grade hPSCs and 3D-tissue morphogenesis in vitro could
become available for regenerative medicine and phar-
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